Teva Pharmaceuticals
TEVA
TEVA
535 hedge funds and large institutions have $9.47B invested in Teva Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 66 funds opening new positions, 171 increasing their positions, 217 reducing their positions, and 169 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
52% less capital invested
Capital invested by funds: $19.5B → $9.47B (-$10.1B)
57% less funds holding in top 10
Funds holding in top 10: 21 → 9 (-12)
61% less first-time investments, than exits
New positions opened: 66 | Existing positions closed: 169
Holders
535
Holding in Top 10
9
Calls
$283M
Puts
$539M
Top Buyers
| 1 | +$381M | |
| 2 | +$192M | |
| 3 | +$118M | |
| 4 |
NC
Northern Cross
Boston,
Massachusetts
|
+$87.5M |
| 5 |
HCM
Highfields Capital Management
Boston,
Massachusetts
|
+$74M |
Top Sellers
| 1 | -$444M | |
| 2 | -$295M | |
| 3 | -$224M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$175M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$114M |